Back
Halozyme Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
81
HALO
Halozyme Therapeutics, Inc.
Last Price:
$79.45
Seasonality Move:
2.2%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing slight buying pressure.
Halozyme Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 79.27 | Buy |
| 20-day SMA: | 74.85 | Buy |
| 50-day SMA: | 70.53 | Buy |
| 200-day SMA: | 65.53 | Buy |
| 8-day EMA: | 78.35 | Buy |
| 20-day EMA: | 75.9 | Buy |
| 50-day EMA: | 72.64 | Buy |
| 200-day EMA: | 66.64 | Buy |
Halozyme Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.5 | Buy |
| Relative Strength Index (14 RSI): | 62.78 | Buy |
| Chaikin Money Flow: | 66764 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.59 - 78.07) | Buy |
| Bollinger Bands (100): | (65.24 - 74.22) | Buy |
Halozyme Therapeutics, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics, Inc. Stock
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 79.44 while HALO 8-day simple moving average is 79.27, which is a Buy signal.
-
The stock price of HALO is 79.44 while Halozyme Therapeutics, Inc. 20-day SMA is 74.85, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day simple moving average is 70.53 while HALO share price is 79.44, making it a Buy technically.
-
HALO stock price is 79.44 and Halozyme Therapeutics, Inc. 200-day simple moving average is 65.53, creating a Buy signal.
HALO Technical Analysis vs Fundamental Analysis
Buy
81
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy or a Sell?
-
Halozyme Therapeutics, Inc. stock is rated a BuyThe current Halozyme Therapeutics, Inc. [HALO] share price is $79.44. The Score for HALO is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
Halozyme Therapeutics, Inc. Stock Info
Market Cap:
9.3B
Price in USD:
79.44
Share Volume:
1.7M
Halozyme Therapeutics, Inc. 52-Week Range
52-Week High:
82.22
52-Week Low:
47.50
Buy
81
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Halozyme Therapeutics, Inc. Share Price Forecast
-
What is the Halozyme Therapeutics, Inc. stock price today?The Halozyme Therapeutics, Inc. stock price is 79.44 USD today.
-
Will HALO stock go up or go down?Halozyme Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Halozyme Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics, Inc. is not overvalued.
Is Halozyme Therapeutics, Inc. Stock a Buy?
-
Halozyme Therapeutics, Inc. share price is 79.44 while HALO 8-day exponential moving average is 78.35, which is a Buy signal.
-
The stock price of HALO is 79.44 while Halozyme Therapeutics, Inc. 20-day EMA is 75.90, which makes it a Buy.
-
Halozyme Therapeutics, Inc. 50-day exponential moving average is 72.64 while HALO share price is 79.44, making it a Buy technically.
-
HALO stock price is 79.44 and Halozyme Therapeutics, Inc. 200-day simple moving average is 66.64, creating a Buy signal.
Fundamental Analysis of Halozyme Therapeutics, Inc.
Is Halozyme Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.63 per share, and an increase next year of $1.69 per share.
Technical Analysis of Halozyme Therapeutics, Inc.
Should I short Halozyme Therapeutics, Inc. stock?
-
HALO Moving Average Covergence Divergence (MACD) indicator is 2.5, suggesting Halozyme Therapeutics, Inc. is a Buy
-
Halozyme Therapeutics, Inc. Relative Strength Index (RSI) is 62.78, which suggest Halozyme Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Halozyme Therapeutics, Inc. is (70.59 - 78.07), which suggest Halozyme Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Halozyme Therapeutics, Inc. is (65.24 - 74.22), which suggest Halozyme Therapeutics, Inc. is a Buy
* Halozyme Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.